Lv6
2120 积分 2024-01-12 加入
Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology
1天前
求助中
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
2天前
已完结
Special Section on Pharmacokinetics and ADME of Biological Therapeutics–Editorial
25天前
已完结
China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees
1个月前
已完结
A new look at rheumatology in China—opportunities and challenges
1个月前
已完结
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
1个月前
已完结
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies
2个月前
已关闭
Myasthenia Gravis Impairment Index
5个月前
已完结
Efficacy and safety of efgartigimod versus intravenous immunoglobulin in early intervention of acetylcholine receptor antibody-positive impending myasthenic crisis: A retrospective cohort study
7个月前
已完结
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets
7个月前
已完结
皖公网安备34019202002308
